Chemical ligands, genomics and drug discovery

Drug Discovery Today

Volumn 5, Issue 4, 2000, Pages 145-156

  Lenz, George R ^a   Nash, Huw M ^a   Jindal, Satish ^a  

^a NeoGenesis Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

BINDING AFFINITY; CAPILLARY ELECTROPHORESIS; COMPUTER AIDED DESIGN; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG SCREENING; DRUG TARGETING; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; MODEL; NONHUMAN; RECEPTOR BINDING; REVIEW; RNA BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; TECHNOLOGY;

EID: 0034177001     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01468-9     Document Type: Review

References (45)

1. Guild B.C. Genomics, target selection, validation, and assay considerations in the development of antibacterial screens. Annu. Rep. Med. Chem. 34:1999;227-236.
2. Duggan D.J.et al. Expression profiling using cDNA arrays. Nat. Genet. 21(Suppl. 1):1998;10-14.
3. Lottspeich F. Proteome analysis: A pathway to the functional analysis of proteins. Angew. Chem., Int. Ed. Engl. 38:1999;2476-2492.
4. Ackerly B.J.et al. Systematic identification of essential genes by in vitro mariner mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8927-8932.
5. Altschul S.F.et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
6. Rychlewski L.et al. Functional insights from structural predictions: Analysis of the Escherichia coli genome. Protein Sci. 8:1999;614-624.
7. Pawlowski K.et al. The Helicobacter pylori genome: From sequence analysis to structural and functional predictions. Proteins. 36:1999;20-30.
8. Šali A. Arise, go forth, and solve structures. Nat. Struct. Biol. 5:1998;1029-1032.
9. Shortle D. Structure prediction: The state of the art. Curr. Biol. 9:1999;R205-R209.
10. Sternberg M.J.E.et al. Progress in protein structure prediction: Assessment of CASP3. Curr. Opin. Struct. Biol. 9:1999;368-373.
11. Zhang B.et al. From fold predictions to function predictions: Automation of functional site conservation analysis for functional genome predictions. Protein Sci. 8:1999;1104-1115.
12. Wei L.et al. Are predicted structures good enough to preserve functional sites. Structure. 7:1999;643-650.
13. Park J.et al. Sequence comparisons using multiple sequences detect three times as many remote homologs as pairwise methods. J. Mol. Biol. 284:1998;1201-1210.
14. Brenner S.E.et al. Assessing sequence comparison methods with reliable structurally identified distant evolutionary relationships. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6073-6078.
15. Mendelsohn A.R., Brent R. Protein interaction methods - towards an end game. Science. 284:1999;1948-1950.
16. Marcotte E.M.et al. Detecting protein function and protein-protein interactions from genome sequences. Science. 285:1999;751-753.
17. Wrighton N.C.et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 273:1996;458-463.
18. Chirinos-Rojas C.L.et al. A peptidomimetic antagonist of TNF-alpha-mediated cytotoxicity identified from a phage-displayed random peptide library. J. Immunol. 161:1998;5621-5626.
19. Schatz P.J. Construction and screening of biological peptide libraries. Curr. Opin. Biotechnol. 5:1994;487-494.
20. Norman T.C.et al. Genetic selection of peptide inhibitors of biological pathways. Science. 285:1999;591-595.
21. Eliseev A.V. Emerging approaches to target-assisted screening of combinatorial mixtures. Curr. Opin. Drug Dis. Dev. 1:1998;106-115.
22. Tan D.S.et al. Synthesis and preliminary evaluation of a library of polycyclic small molecules for use in chemical genetic assays. J. Amer. Chem. Soc. 121:1999;9073-9087.
23. Tan D.S.et al. Stereoselective synthesis of over two million compounds having structural features both reminiscent of natural products and compatible with miniaturized cell-based assays. J. Amer. Chem. Soc. 120:1998;8565-8566.
24. Lenz G.R. Optimizing small-molecule drug targets: Focus on combinatorial chemistry. Spectrum Reports: Drug Discovery and Design Decision Resources. 16:1998;1-15.
25. Nestler H.P.et al. A general method for molecular tagging of encoded combinatorial libraries. J. Org. Chem. 59:1994;4723-4724.
26. Borchardt A.et al. Small-molecule dependent genetic selection in stochastic nanodroplets as a means of detecting protein-ligand interactions on a large scale. Chem. Biol. 4:1997;961-968.
27. You A.J.et al. A miniaturized arrayed assay format for detecting small molecule-protein interactions in cells. Chem. Biol. 4:1997;969-975.
28. MacBeath G.et al. Printing small molecules as microarrays and detecting protein-ligand interactions en masse. J. Amer. Chem. Soc. 121:1999;7967-7968.
29. Jindal S., Lenz G.R. Affinity selection: An emerging technology for drug discovery. Spectrum Reports: Drug Discovery and Design Decision Resources. 20:1998;1-13.
30. Kay B.K.et al. From peptides to drugs via phage display. Drug Discovery Today. 3:1998;370-378.
31. Bowie, J.U. and Pakula, A.A. (1996) Scriptgen Pharmaceuticals screening method for identifying ligands for target proteins. US 5585277.
32. Kaur S.et al. Affinity selection and mass spectrometry-based strategies to identify lead compounds in combinatorial libraries. J. Protein. Chem. 16:1997;505-511.
33. Carell T.et al. A novel procedure for the synthesis of libraries containing small organic molecules. Angew. Chem., Int. Ed. Engl. 33:1994;2059-2061.
34. Dunayevskiy Y.M.et al. Application of capillary electrophoresis-electrospray ionization mass spectrometry in the determination of molecular diversity. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6152-6157.
35. Shapiro M.J., Wareing J.R. High resolution NMR for screening ligand/protein binding. Curr. Opin. Drug Dis. Dev. 2:1999;396-400.
36. Hajduk P.J.et al. High-throughput nuclear magnetic resonance-based screening. J. Med. Chem. 42:1999;2315-2317.
37. Ecker D.J., Griffey R.H. RNA as a small-molecule drug target: Doubling the value of genomics. Drug Discovery Today. 4:1999;420-429.
38. Griffey R.H.et al. Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10129-10133.
39. Griffey R.H.et al. Targeted site-specific gas-phase cleavage of oligoribonucleotides. Application in mass spectrometry-based identification of ligand binding sites. J. Amer. Chem. Soc. 121:1999;474-475.
40. Hofstadler S.A.et al. Multiplexed screening of neutral mass-tagged RNA targets against ligand libraries with electrospray ionization FTICR MS: A paradigm for high-throughput affinity screening. Anal. Chem. 71:1999;3436-3440.
41. Wintner, E.A. and Moallemi, C.C. Quantized surface complementarity diversity: A model based on small molecule-target complementarity. J. Med. Chem. (in press).
42. Drews J. Strategic choices facing the pharmaceutical industry: A case for innovation. Drug Discovery Today. 2:1997;72-78.
43. Drews J. Genomic sciences and the medicine of tomorrow. Nat. Biotechnol. 14:1996;1516-1518.
44. Tian S.S.et al. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science. 281:1998;257-259.
45. Zhang B.et al. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science. 284:1999;974-977.